Tuesday, October 14, 2014

Reader points out a topical ketamine cominvation drug patent designed to bypass scientific/medical vetting and FDA approval process by using pharmacy compounding as a development and marketing platform

Anonymous said...
Here's a topical ketamine combination drug PATENT designed to bypass scientific/medical vetting and FDA approval by using pharmacy compounding as a development and marketing platform. The patent claims up to 50% penetration of ketamine applied topically. Matters involving bladder, renal and CNS safety and abuse potential with prescribed intermittent/chronic exposures and diversion for date-rape remain very concerning--particularly where the drugs are promoted to sports departments on college campuses and the U.S. Military. See patent here: http://www.google.com/patents/US20130085171

No comments: